Troplasminogen alfa

DB18985InvestigationalProtein Based Therapies

Troplasminogen alfa is under investigation in clinical trial NCT00144014 (Safety and Efficacy Study in Acute Ischaemic Stroke).

Code names
BB-10153 · V-10153

Resolves to

Compound
UNIIM6PBS85QD0CAS931101-84-7

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Troplasminogen alfa, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In